Cellular Tumor Antigen p53 (Tumor Suppressor p53 or Antigen NY CO 13 or TP53) – Pipeline Insight, H1 2018
Albany, US, 2018-Mar-21 — /EPR Network/ — Market Research HUB has recently added a new Pharmaceutical and Healthcare disease pipeline guide Cellular Tumor Antigen p53 [read full press release…]
